Importance of the neutrophil-to-lymphocyte ratio in muscle-invasive and non-muscle invasive bladder tumors

被引:25
|
作者
Ceylan, Cavit [1 ]
Doluoglu, Omer G. [2 ]
Keles, Ibrahim [3 ]
Gazel, Eymen [1 ]
Temucin, Tulay [4 ]
Odabas, Oner [1 ]
Karalar, Mustafa [3 ]
机构
[1] Yuksek Ihtisas Training & Res Hosp, Dept Urol, Ankara, Turkey
[2] Ankara Numune Training & Res Hosp, Urol Clin, Ankara, Turkey
[3] Afyon Kocatepe Univ, Med Fac, Urol Clin, Afyon, Turkey
[4] Yuksek Ihtisas Training & Res Hosp, Dept Pathol, Clin Turkiye, Ankara, Turkey
关键词
Neutrophil-to-lymphocyte ratio; Transurethral resection; Urinary bladder neoplasm;
D O I
10.5301/uro.5000031
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To research the importance of the neutrophil-to-lymphocyte ratio (NLR) in muscleinvasive bladder cancers (MIBC) and non-muscle invasive bladder cancer (NMIBC). Methods: Data of 198 patients who underwent TUR-TM in our clinic were retrospectively evaluated. Patients were divided into two groups: group-I (MIBC) and group-II (NMIBC). The neutrophil and lymphocyte counts, NLR, hemoglobin and hematocrit values, tumor numbers, sizes and degrees of patients were recorded. Within the inter-group comparison, Mann-Whitney U test was used for the values stated with measuring, whereas a Chi-square test was used for the values stated with counting. The cut-off value for the NLR was determined with ROC curve. Results: The NLR values of group-I and group-II were found as 4.14 +/- 2.76 and 3.36 +/- 2.88, respectively (p = 0.03). Whether the NLR carries a differential property was evaluated with ROC curve. The cut-off value was estimated as 3.96 according to the Youden index. With this value, sensitivity was found as 50%, specificity was 22.8% and AUC was 0.615 (p = 0.03). Discussion: According to the data in this study, it can be said that Ta-T1 tumors are likely to be invasive by 50% if the NLR value is greater than 3.96.
引用
收藏
页码:120 / 124
页数:5
相关论文
共 50 条
  • [31] PROGNOSTIC VALUES OF PREOPERATIVE NEUTROPHIL-TO-LYMPHOCYTE RATIO, PLATELET-TO-LYMPHOCYTE RATIO AND LYMPHOCYTE-TO-MONOCYTE RATIO FOR PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER UNDERGOING RADICAL CYSTECTOMY
    Lei, Yonghua
    Jiao, Dian
    Yao, Zhen
    Wang, Lei
    Zhao, Zhiguang
    ARCHIVOS ESPANOLES DE UROLOGIA, 2022, 75 (03): : 287 - 294
  • [32] Bench-to-bedside translation of ciclopirox prodrug for the treatment of non-muscle invasive and muscle-invasive bladder cancer
    Weir, Scott J.
    Ranjarajan, Partha
    Wood, Robyn
    Schorno, Karl
    Ramamoorthy, Prabhu
    Rajweski, Lian
    Heppert, Kathy
    McKenna, Michael J.
    McCulloch, William
    Reed, Greg A.
    Brinker, Amanda
    Baltezor, Michael J.
    Jensen, Roy A.
    Taylor, John A.
    Anant, Shrikant
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Can Neutrophil-to-Lymphocyte ratio predict the response to BCG in high-risk non muscle invasive bladder cancer?
    Racioppi, Marco
    Di Gianfrancesco, Luca
    Ragonese, Mauro
    Palermo, Giuseppe
    Sacco, Emilio
    Bassi, Pier Francesco
    INTERNATIONAL BRAZ J UROL, 2019, 45 (02): : 315 - 324
  • [34] NEUTROPHIL TO LYMPHOCYTE RATIO AS A PREDICTIVE FACTOR OF CISPLATIN BASED NEOADJUVANT CHEMOTHERAPY IN MUSCLE-INVASIVE BLADDER CANCER
    Mascia, Roberta
    Verri, Elena
    Rocca, Maria Cossu
    Aurilio, Gaetano
    Cullura, Daniela
    Musi, Gennaro
    Cozzi, Gabriele
    Russo, Andrea
    De Cobelli, Ottavio
    Nole, Franco
    ANTICANCER RESEARCH, 2018, 38 (04) : 2518 - 2521
  • [35] Neutrophil-Lymphocyte Ratio and Pathological Response to Neoadjuvant Chemotherapy in Patients With Muscle-Invasive Bladder Cancer
    Seah, Jo-An
    Leibowitz-Amit, Raya
    Atenafu, Eshetu G.
    Alimohamed, Nimira
    Knox, Jennifer J.
    Joshua, Anthony M.
    Sridhar, Srikala S.
    CLINICAL GENITOURINARY CANCER, 2015, 13 (04) : E229 - E233
  • [36] The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking
    Ogihara, Koichiro
    Kikuchi, Eiji
    Yuge, Kazuyuki
    Yanai, Yoshinori
    Matsumoto, Kazuhiro
    Miyajima, Akira
    Asakura, Hirotaka
    Oya, Mototsugu
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S1039 - S1047
  • [37] The Preoperative Neutrophil-to-lymphocyte Ratio is a Novel Biomarker for Predicting Worse Clinical Outcomes in Non-muscle Invasive Bladder Cancer Patients with a Previous History of Smoking
    Koichiro Ogihara
    Eiji Kikuchi
    Kazuyuki Yuge
    Yoshinori Yanai
    Kazuhiro Matsumoto
    Akira Miyajima
    Hirotaka Asakura
    Mototsugu Oya
    Annals of Surgical Oncology, 2016, 23 : 1039 - 1047
  • [38] Prognostic role of pretreatment neutrophil-to-lymphocyte ratio (NLR) in patients with non muscle-invasive bladder cancer (NMIBC): A systematic review and meta-analysis
    Vartolomei, Mihai Dorin
    Porav-Hodade, Daniel
    Ferro, Matteo
    Mathieu, Romain
    Abufaraj, Mohammad
    Foerster, Beat
    Kimura, Shoji
    Shariat, Shahrokh F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (09) : 389 - 399
  • [39] Bladder cancer susceptibility polymorphisms and mortality from non-muscle and muscle-invasive bladder cancer.
    Leeming, Reno C.
    Zens, Michael S.
    Seigne, John D.
    Christensen, Brock C.
    Gilbert-Diamond, Diane
    Karagas, Margaret R.
    Passarelli, Michael N.
    CLINICAL CANCER RESEARCH, 2020, 26 (15) : 54 - 55
  • [40] Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer
    S. Singer
    C. Ziegler
    T. Schwalenberg
    A. Hinz
    H. Götze
    T. Schulte
    Supportive Care in Cancer, 2013, 21 : 1383 - 1393